News

The patent, titled ‘Catalysts,’ US 7,651,875, was issued by the US Patent and Trademark Office (USPTO) on January 26. It covers some of the many potential applications of

Sohm said that the strategic alliance with the manufacturing house currently has a range of 85 products covering major therapeutic categories and marketing within the northern region of

Helix Medical Europe begins production this month at their newly built, 55,000 square foot facility located in Kaiserslautern, Germany. Initial manufacturing services will include custom molding of silicone

The trial investigated five ascending doses of PXS25 in 40 subjects. At all doses, PXS25 was found to be safe and well tolerated with a pharmacokinetic profile consistent

A0001 or alpha-tocopherolquinone, is a coenzyme Q analog demonstrated to improve mitochondrial function in-vitro. The study is being conducted at the Newcastle upon Tyne Hospitals in Newcastle, England.

The study is designed to evaluate the safety and tolerability of different doses of ecopipam in adults (group 1), adolescents (group 2) and children (group 3), with LND.

CytoSolv is a newly formed Rhode Island biomedical company, developing proprietary technology to address wound healing, initially targeting diabetic ulcers. Its technology involves the delivery of a mixture

The primary endpoint in the double-blind safety study is evaluation of blood pressure effects of subcutaneous Bremelanotide in men between 45 and 65 years old. The study is

Denosumab demonstrated superiority over Zometa for both delaying the time to the first on-study skeletal related event (fracture, radiation to bone, surgery to bone or spinal cord compression)